Ultraviolet radiation induced signature mutations in photocarcinogenesis

Journal of Investigative Dermatology Symposium Proceedings

Volumn 4, Issue 1, 1999, Pages 6-10

  Wikonkal, Norbert M ^a,b   Brash, Douglas E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Basal cell cancer; P53; PTCH; Squamous cell cancer

Indexed keywords

GENE PRODUCT; PROTEIN P53; PROTEIN PATCHED; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BASAL CELL CARCINOMA; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; KERATINOCYTE; MOUSE; NONHUMAN; PHOTON; RADIATION CARCINOGENESIS; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUNLIGHT; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

EID: 0032881840     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jidsp.5640173     Document Type: Conference Paper

References (46)

1. Berg RJ, van Kranen GJ, Rebel HG, et al: Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci USA 93:274-278, 1996
2. Blackwood MA, Weber BL: BRCA1 and BRCA2: from molecular genetics to clinical medicine. J Clin Oncol 16:1969-1977, 1998
3. Brash DE, Rudolph JA, Simon JA, et al: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128, 1991
4. Campbell C, Quinn AG, Ro YS, Angus B, Rees JL: p53 mutations are common and early events that precede tumor invasion in squamous ell neoplasia of the skin. J Invest Dermatol 100:746-748, 1993
5. de la Chapelle A, Peltomaki P: The genetics of hereditary common cancers. Curr Opin Genet Dev 8:298-303, 1998
6. Chidambaram A, Goldstein AM, Gailani MR, et al: Mutations in the human homologue of the Drosophila patched gene in Caucasian and African-American nevoid basal cell carcinoma syndrome patients. Cancer Res 56:4599-4601, 1996
7. Drobetsky EA, Grosovsky AJ, Glickman BW: The specificity of UV-induced mutations at an endogenous locus in mammalian cells. Proc Natl Acad Sci USA 84:9103-9170, 1987
8. Duncan JA, Reeves JR, Cooke TG: BRCA1 and BRCA2 proteins: roles in health and disease. Mol Pathol 51:237-247, 1998
9. Fan H, Oro AE, Scott MP, Khavari PA: Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog. Nat Med 3:788-792, 1997
10. Fearon ER, Dang CV: Tumor suppressor meets oncogene. Curr Biol 9:R62-R65, 1999
11. Gailani MR, Bale AE: Developmental genes and cancer: role of patched in basal cell carcinoma of the skin. J Natl Cancer Inst 89:1103-1109, 1997
12. Gailani MR, Stahle-Backdahl M, Leffell DJ, et al: The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 14:78-81, 1996
13. Gallie BL, Campbell C, Devlin H, Duckett A, Squire JA: Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res 59:1731s-1735s, 1999
14. Gorlin RJ: Nevoid basal cell carcinoma syndrome. Dermatol Clin 13:113-125, 1995
15. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878, 1994
16. Hahn H, Wicking C, Zaphiropoulous PG, et al: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841-851, 1996
17. Hall PA, Lane DP: p53 in tumour pathology: can we trust immunohistochemistry? J Pathol 172:1-4, 1994
18. Hooper ML: Tumour suppressor gene mutations in humans and mice: parallels and contrasts. EMBO J 17:6783-6789, 1998
19. Johnson RL, Rothman AL, Xie J, et al: Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272:1668-1671, 1996
20. Jonason AS, Kunala S, Price GJ, et al: Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 93:14025-14029, 1996
21. Lane DP: Cancer. p53, guardian of the genome. Nature 358:15-16, 1992
22. Lawrence CW: Are pyrimidine dimers non-instructive lesions: Mol Gen Genet 182:511-513, 1981
23. Lever WF: Lever's Histopathology of the Skin, 8th edn. Philadelphia: Lippincott-Raven, 1997
24. Ljungman M, Zhang F: Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis. Oncogene 13:823-831, 1996
25. Makino T, Tatebe S, Goto A, Mihara M, Ito H: Apoptosis and cellular proliferation in human epidermal squamous cell neoplasia. J Cutan Pathol 25:136-142, 1998
26. Maltzman W, Czyzyk L: UV irradiation simulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4:1689-1694, 1984
27. Marks R, Foley P, Goodman G, Hage BH, Selwood TS: Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol 115:649-655, 1986
28. Miller JH: Mutagenic specificity of ultraviolet light. J Mol Biol 182:45-68, 1985
29. Miller SJ: Biology of basal cell carcinoma. J Am Acad Dermatol 24:1-13, 161-175, 1991
30. Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72-73, 1994
31. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein EH, Scott MP: Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 276:817-821, 1997
32. Pontén F, Berg C, Ahmadian A, et al: Molecular pathology in basal cell cancer with p53 as a genetic marker. Oncogene 15:1059-1067, 1997
33. Ren ZP, Hedrum A, Pontén F, et al: Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene 12:765-773, 1996
34. Riddle RD, Johnson RL, Laufer E, Tabin C: Sonic hedgehog mediates the polarizing activity of the ZPA. Cell 75:1401-1416, 1993
35. Roelink H, Porter JA, Chiang C, et al: Floor plate and motor neuron induction by different concentrations of the amino-terminal cleavage product of sonic hedgehog autoproteolysis. Cell 81:445-455, 1995
36. Schaaper RM, Kunkel TA, Loeb LA: Infidelity of DNA synthesis associated with bypass of apurinic sites. Proc Natl Acad Sci USA 80:487-491, 1983
37. Springate JE: The nevoid basal cell carcinoma syndrome. J Pediatr Surg 21:908-910, 1986
38. Strauss BS: The 'A rule' of mutagen specificity: a consequence of DNA polymerase bypass of non-instructional lesions? BioEssays 13:79-84, 1991
39. Symonds H, Krall L, Remington L, Saenz Robles M, Lowe S, Jacks T, Van Dyke T: p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703-711, 1994
40. Tsuji T, Kitajima S, Koashi Y: Expression of proliferating cell nuclear antigen (PCNA) and apoptosis related antigen (LeY) in epithelial skin tumors. Am J Dermatopathol 20:164-169, 1998
41. Unden AB, Holmberg E, Lundh-Rozell B, et al: Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: different in vivo mechanisms of PTCH inactivation. Cancer Res 56:4562-4565, 1996
42. Wicking C, Shanley S, Smyth I, et al: Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the patched protein, and no genotype-phenotype correlations are evident. Am J Hum Genet 60:21-26, 1997
43. Wikonkal NM, Berg RJ, van Haselen CW, et al: bcl-2 vs p53 protein expression and apoptotic rate in human nonmelanoma skin cancers. Arch Dermatol 133:599-602, 1997
44. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl CM: Wild-type p53 restores cell cycle control and inhibits gene amplification in cell with mutant p53 alleles. Cell 70:937-948, 1992
45. Ziegler A, Leffell DJ, Kunala S, et al: Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 90:4216-4220, 1993
46. Ziegler A, Jonason AS, Leffell DJ, et al: Sunburn and p53 in onset of skin cancer. Nature 372:773-776, 1994